Jubrail Dahabreh

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · The Lancet Oncology · 2016 · 489 citations · Full text

Oncology, Immunology, Bronchial Neoplasm +8

Adjuvant MAGE-A3 Immunotherapy in Resected Non–Small-Cell Lung Cancer: Phase II Randomized Study Results

Johan Vansteenkiste, M. Zieliński, A. Linder et al. · Journal of Clinical Oncology · 2013 · 312 citations · Full text

Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer

Vaios Karanikas, Theodora Kerenidi, Jubrail Dahabreh et al. · Cancer Biology & Therapy · 2007 · 91 citations · Full text

Magrit, a Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of the Recmage-A3 + As15 Cancer Immunotherapeutic As Adjuvant Therapy in Patients with Resected Mage-A3-Positive Non-Small Cell Lung Cancer (Nsclc)

Johan Vansteenkiste, Byoung Chul Cho, Tõnu Vanakesa et al. · Annals of Oncology · 2014 · 53 citations

Medicine, Tumor Immunity, Bronchial Neoplasm +8

Primary Malignant Melanoma of the Lung: A Case Report

Apostolos Dountsis, Charalambos Zisis, Evangelia Karagianni et al. · World Journal of Surgical Oncology · 2003 · 52 citations · Full text